Trial intelligence / Profile preview

Dexmedetomidine for improving wake-up test quality during corrective spine surgery

PACTR202010818690380Phase 3Completed

Sponsor
faculty of Medicine
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of dexmedetomidine in anaesthesia (2 arms), sponsored by faculty of Medicine. Primary endpoint: Quality of the wake-up test. Started Oct 2020; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

anaesthesia

Beyond the preview

Go deeper on PACTR202010818690380.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202010818690380.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call